XML 67 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Collaboration, Licensing and Other Arrangements - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended 20 Months Ended
Dec. 31, 2020
Sep. 30, 2019
May 31, 2018
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2020
Nov. 30, 2020
Oct. 31, 2018
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue' collaborations and services       $ 17,436,000   $ 16,235,000      
Deferred revenue - current $ 33,275,000     25,880,000     $ 33,275,000    
Deferred revenue - long term 1,662,000     1,626,000     1,662,000    
Commercial product sales                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue' collaborations and services       8,099,000   $ 8,000,000      
Collaboration and License Agreement | United Therapeutics Corporation                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Upfront payment received                 $ 45,000,000.0
Milestone Payment Received               $ 12,500,000  
Deferred revenue       25,600,000          
Increase in total consideration $ 2,700,000                
Collaboration and License Agreement | United Therapeutics Corporation | Clinical Supplies                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Total transaction price       105,800,000          
Collaboration and License Agreement | United Therapeutics Corporation | Maximum                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Additional option exercise and development milestone payments to be receive       40,000,000.0          
Co-Promotion Agreement | Vertice Pharma LLC                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Total transaction price       6,300,000          
Supply and Distribution Agreement | Biomm | Commercial product sales                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue' collaborations and services   $ 700,000   0 $ 200,000   $ 0    
License and Distribution Agreement | Cipla Ltd                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue       1,800,000          
Marketing and distribution agreement date     2018-05            
Deferred revenue - current       200,000          
Deferred revenue - long term       $ 1,600,000